All data are based on the daily closing price as of February 3, 2026
c
Chong Kun Dang Pharmaceutical
185750.KO
58.91 USD
1.33
+2.31%
Overview
Last close
58.91 usd
Market cap
776.24M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
78.04 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.6631
Price/Book Value
1.2145
Enterprise Value
843.45M usd
EV/Revenue
0.7256
EV/EBITDA
10.9741
Key financials
Revenue TTM
1.16B usd
Gross Profit TTM
364.02M usd
EBITDA TTM
74.48M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
1.09B usd
Net debt
58.95M usd
About
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.